PROKIDNEY CORP. — Director's Dealing 2024

Sep 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2024-09-13

Reporting Person: Culleton Bruce (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-13	Employee stock option (right to buy)	$1.69	A	500000	Acquired	2033-12-03	Class A Ordinary Shares (500000)	Direct

Footnotes

F1: This performance-based stock option was granted on December 3, 2023. On September 13, 2024, the Company's board of directors certified achievement of the performance goal at 100%. In addition to the achievement of the performance goal, the options are subject to time vesting requirements under which 25% vested on September 13, 2024 and the remaining 75% vests in equal installments of 125,000 shares on each of November 15, 2024, February 15, 2025 and May 15, 2025.